Rock Springs Capital Master Fund Lp - Net Worth and Insider Trading

Over the past 18 months, Rock Springs Capital Master Fund Lp made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net purchase of 1,833,697 shares made by Robert Lorne Hopfner , a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. , and a net sale of 7,523 shares made by Douglas A Treco .

In summary, during the past 3 months, insiders sold 7,523 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 7,523 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc (INZY) were sold and 2,667,030 shares were bought by its insiders, resulting in a net purchase of 2,659,507 shares.

Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Rock Springs Capital Master Fund Lp made no insider transaction in Imara Inc (IMRA). Other recent insider transactions involving Imara Inc (IMRA) include a net sale of 2,590,000 shares made by Braden Michael Leonard , a net purchase of 29,899 shares made by Ra Capital Healthcare Fund Lp , and a net sale of 11,313 shares made by Rahul D. Ballal .

In summary, during the past 3 months, insiders sold 0 shares of Imara Inc (IMRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,604,909 shares of Imara Inc (IMRA) were sold and 29,899 shares were bought by its insiders, resulting in a net sale of 2,575,010 shares.

Imara Inc (IMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Rock Springs Capital Master Fund Lp made no insider transaction in Homology Medicines Inc (FIXX). Other recent insider transactions involving Homology Medicines Inc (FIXX) include a net sale of 21,335 shares made by Paul Alloway , a net sale of 23,653 shares made by Arthur Tzianabos , and a net sale of 5,068 shares made by Albert Seymour .

In summary, during the past 3 months, insiders sold 0 shares of Homology Medicines Inc (FIXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,328 shares of Homology Medicines Inc (FIXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,328 shares.

Homology Medicines Inc (FIXX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Tempest Therapeutics Inc (TPST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tempest Therapeutics Inc (TPST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tempest Therapeutics Inc (TPST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Rock Springs Capital Master Fund Lp made no insider transaction in Atea Pharmaceuticals Inc (AVIR). Other recent insider transactions involving Atea Pharmaceuticals Inc (AVIR) include a net sale of 56,910 shares made by Jean-pierre Sommadossi , a net sale of 41,666 shares made by Franklin M Berger , and a net sale of 15,870 shares made by Maria Arantxa Horga .

In summary, during the past 3 months, insiders sold 126,948 shares of Atea Pharmaceuticals Inc (AVIR) in total and bought 0 shares, with a net sale of 126,948 shares. During the past 18 months, 168,614 shares of Atea Pharmaceuticals Inc (AVIR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 168,614 shares.

Atea Pharmaceuticals Inc (AVIR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Rock Springs Capital Master Fund Lp made no insider transaction in Theseus Pharmaceuticals Inc (THRX). Other recent insider transactions involving Theseus Pharmaceuticals Inc (THRX) include a net purchase of 1,200,000 shares made by Foresite Capital Fund V, L.p. , a net purchase of 671,932 shares made by Carl L Gordon , and a net purchase of 671,932 shares made by Orbimed Advisors Llc .

In summary, during the past 3 months, insiders sold 0 shares of Theseus Pharmaceuticals Inc (THRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Theseus Pharmaceuticals Inc (THRX) were sold and 2,557,866 shares were bought by its insiders, resulting in a net purchase of 2,557,866 shares.

Theseus Pharmaceuticals Inc (THRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Rock Springs Capital Master Fund Lp made no insider transaction in Xilio Therapeutics Inc (XLO). Other recent insider transactions involving Xilio Therapeutics Inc (XLO) include a net sale of 5,235 shares made by Atlas Venture Fund Xi, L.p. , and a net purchase of 485,250 shares made by Gilead Sciences Inc .

In summary, during the past 3 months, insiders sold 1,000 shares of Xilio Therapeutics Inc (XLO) in total and bought 485,250 shares, with a net purchase of 484,250 shares. During the past 18 months, 5,235 shares of Xilio Therapeutics Inc (XLO) were sold and 485,250 shares were bought by its insiders, resulting in a net purchase of 480,015 shares.

Xilio Therapeutics Inc (XLO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Rock Springs Capital Master Fund Lp made no insider transaction in Verve Therapeutics Inc (VERV). Other recent insider transactions involving Verve Therapeutics Inc (VERV) include a net purchase of 1,587,538 shares made by Krishna Yeshwant , a net sale of 424,925 shares made by Gv 2017 Gp, L.l.c. , and a net sale of 1,108 shares made by Allison Dorval .

In summary, during the past 3 months, insiders sold 1,514 shares of Verve Therapeutics Inc (VERV) in total and bought 0 shares, with a net sale of 1,514 shares. During the past 18 months, 640,874 shares of Verve Therapeutics Inc (VERV) were sold and 1,800,000 shares were bought by its insiders, resulting in a net purchase of 1,159,126 shares.

Verve Therapeutics Inc (VERV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Rock Springs Capital Master Fund Lp made no insider transaction in Enliven Therapeutics Inc (ELVN). Other recent insider transactions involving Enliven Therapeutics Inc (ELVN) include a net sale of 131,709 shares made by Samuel Kintz , a net sale of 114,000 shares made by Joseph P Lyssikatos , and a net sale of 51,625 shares made by Anish Patel .

In summary, during the past 3 months, insiders sold 1,636,358 shares of Enliven Therapeutics Inc (ELVN) in total and bought 0 shares, with a net sale of 1,636,358 shares. During the past 18 months, 2,418,854 shares of Enliven Therapeutics Inc (ELVN) were sold and 622 shares were bought by its insiders, resulting in a net sale of 2,418,232 shares.

Enliven Therapeutics Inc (ELVN)'s detailed insider trading history can be found in Insider Trading Tracker table.